<DOC>
	<DOCNO>NCT02635724</DOCNO>
	<brief_summary>This study evaluate safety , pharmacokinetics effectiveness single dose 600 mg IV peramivir treatment elderly subject acute uncomplicated influenza infection subject acute uncomplicated influenza infection high risk influenza complication . All subject receive IV peramivir .</brief_summary>
	<brief_title>Safety , PK Effectiveness IV Peramivir Elderly Higher Risk Subjects With Uncomplicated Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Peramivir</mesh_term>
	<criteria>A positive influenza Rapid Antigen Test ( RAT ) and/or FDAapproved PCR test least one clinical sign symptom consistent acute influenza infection list OR Clinical sign symptoms consistent acute influenza infection consist oral temperature ≥ 100°F ( 37.8°C ) least one respiratory symptom least moderate severity ( cough rhinitis ) least one constitutional symptom least moderate severity ( myalgia [ ache pain ] , headache , feverishness , fatigue ) Influenza symptom onset &lt; 48 hour Pregnant female Subjects require hospital admission Recent worsen chronic medical condition consistent complication influenza Current evidence bacterial infection require antibiotic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acute uncomplicated</keyword>
	<keyword>Elderly</keyword>
</DOC>